BioSpace News Archive

Business

Digirad Corporation Announces 2019 Fourth Quarter and Year End Financial ResultsReports Q4 2019 Revenue and Gross Profit Increases of 39% and 112%, Respectively

Digirad Corporation reported its financial results for the fourth quarter and year ended December 31, 2019.

March 6, 2020
·
16 min read
Business

Bio-Path Holdings Reports Full Year 2019 Financial ResultsConference Call to be Held Today at 8:30 A.M. ET

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the full year ended December 31, 2019

March 6, 2020
·
6 min read
Pharm Country

Cold Plasma Market Revenue and Value Chain 2020-2029

A recent research report on Global Cold Plasma Market 2020 deeply studied great features of the industry.

March 6, 2020
·
4 min read
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft Survival of 89% After Imlifdase Treatment and Transplantation

Two poster sessions were highlighted at the Cutting Edge of Transplantation summit 2020. Balancing equity and utility in the face of an organ shortage

March 6, 2020
·
3 min read
Pharm Country

Biomarker Research Services Market 10-Year Market Forecast and Trends Analysis

A recent research report on Global Biomarker Research Services Market 2020 deeply studied great features of the industry.

March 6, 2020
·
5 min read
Pharm Country

Advanced Wound Care Market Market Growth, Trends, Absolute Opportunity and Value Chain 2020-2029

A recent research report on Global Advanced Wound Care Market 2020 deeply studied great features of the industry.

March 6, 2020
·
5 min read
Pharm Country

Anaesthesia Machine Market to Create Favourable Opportunities for Producers 2020 to 2029

A recent research report on Global Anaesthesia Machine Market 2020 deeply studied great features of the industry.

March 6, 2020
·
4 min read
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million

ADVANZ PHARMA Corp. Limited (“ADVANZ PHARMA” or “the Company”) (TSX:ADVZ), today announced it signed a definitive agreement to acquire the rights to a portfolio of alprostadil products in 10 European Union countries, as well as the United Kingdom, Russia, Ukraine and Brazil, from UCB S.A.

March 6, 2020
·
5 min read
Pharm Country

Rochester RHIO Turns to eHealth Technologies to Deliver Solutions for 3D Image Sharing

As innovations in cancer screening through diagnostic imaging continue to help clinicians accurately detect and diagnose, challenges to the ability to share large file sizes has increased.

March 6, 2020
·
5 min read
Biotech Beach

PreludeDx Announces New Response Type Biosignature Data at the 37th Annual Miami Breast Cancer Conference

Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced today the presentation of multiple posters at the 37th Annual Miami Breast Cancer Conference

March 6, 2020
·
4 min read